Disposition of 12808 shares by Kevin Lind of Longboard Pharmaceuticals at 3.1232 subject to Rule 16b-3
LBPHDelisted Stock | USD 59.98 0.00 0.00% |
Under 52% of Longboard Pharmaceuticals' traders are presently thinking to get in. The analysis of overall sentiment of trading Longboard Pharmaceuticals stock suggests that some investors are interested at this time. Longboard Pharmaceuticals' investing sentiment shows overall attitude of investors towards Longboard Pharmaceuticals.
Longboard |
Filed transaction by Longboard Pharmaceuticals Director, Officer: Ceo. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Longboard Pharmaceuticals Fundamental Analysis
We analyze Longboard Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Longboard Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Longboard Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Longboard Pharmaceuticals is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Longboard Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Longboard Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Longboard Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Longboard Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Longboard Pharmaceuticals Related Equities
GLUE | Monte Rosa | 6.45 | ||||
SNSE | Sensei Biotherapeutics | 4.65 | ||||
DSGN | Design Therapeutics | 4.34 | ||||
CELC | Celcuity LLC | 3.83 | ||||
STOK | Stoke Therapeutics | 3.36 | ||||
TIL | Instil Bio | 2.64 | ||||
CCCC | C4 Therapeutics | 2.60 | ||||
NXTC | NextCure | 2.11 | ||||
HOWL | Werewolf Therapeutics | 1.27 | ||||
MNOV | MediciNova | 0.46 | ||||
EWTX | Edgewise Therapeutics | 0.06 | ||||
NUVB | Nuvation Bio | 0.37 | ||||
CSBR | Champions Oncology | 0.53 | ||||
MOLN | Molecular Partners | 2.68 | ||||
IKNA | Ikena Oncology | 3.73 | ||||
ASMB | Assembly Biosciences | 3.80 | ||||
ANEB | Anebulo Pharmaceuticals | 10.81 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Longboard Stock
If you are still planning to invest in Longboard Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Longboard Pharmaceuticals' history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |